Background Since evidence of a long-term association between routine blood count (Coulter) variables and coronary heart disease (CHD) is inconsistent, the authors analysed white blood cell count (WBC), red blood cell count (RBC), haemoglobin (Hgb), packed cell volume (PCV) and platelet count for their long-term associations with CHD mortality in the first Northwick Park Heart Study (NPHS-I). NPHS-I has follow-up information for 430 years on 2167 White men and 941 White women and holds entry and follow-up data on haematological variables and other known CHD risk factors.
Introduction
There have been several studies on the association between routine blood count (Coulter) variables and coronary heart disease (CHD). The majority of them were based on relatively short follow-up periods (mostly 10-12 years long). Those that examined white blood cell count (WBC), a marker of inflammatory response including response to the extent of underling atheroma, have reported an association with CHD. [1] [2] [3] [4] [5] [6] [7] However, when the possible modifying effects of gender and smoking habit were investigated, results were not found consistent. 2, 3, 5 Furthermore, the strong correlations between WBC and other Coulter variables, namely red blood cell count (RBC), haemoglobin (Hgb), packed cell volume (PCV) (also known as haematocrit) and platelet count, have generally not been allowed for. One study that showed significant independent associations of WBC with cardiovascular diseases (CVDs) and CHD incidence in non-smoking men is the Framingham study, which had 412 years of followup. It also found a significant, although unadjusted, association with CVD incidence in smoking women. 2 Another long-term study, NHANES I, with 416 years of follow-up, identified a significant association of WBC with CHD incidence both in men and women, with the effect among non-smokers apparently being stronger in the latter. 3 It also found a significant association with CVD mortality among men, even after adjustment for smoking. 3 New analyses of the NHANES I study after 22 years of follow-up identified neutrophil count of WBC as the strongest predictor. 6 NHANES II also reported a significant association of WBC with CHD mortality, after 17 years of follow-up, which was higher in women and persistent among non-smokers. 5 Results have been conflicting when other Coulter variables were examined in relation to CHD, with one prospective study reporting an association for platelet count, 8 whereas a larger study reporting no relationship. 9 Analyses of the Framingham study based on 34 years of follow-up reported an association of PCV with various cardiovascular outcomes, 10 whereas NHASES II found no association of PCV with CHD mortality in men and a weak association in women. 11 None of these long-or short-term studies has examined the joint association of all Coulter variables with CHD.
The way in which Coulter variables might influence CHD has not been elucidated, but one possibility is that they all, or a subset, influence thrombin generation as discussed by Horne et al. 12 We have the opportunity to investigate the joint effect of WBC, RBC, Hgb, PCV and platelet count, measured at entry and once during follow-up 6 years later, on CHD mortality using data from a 30-year long follow-up study on men and women working in London, the first Northwick Park Heart Study (NPHS-I). 13 NPHS-I collected information on several haemostatic, biochemical, clinical, behavioural and Coulter risk factors at recruitment and, for 65% of the initial participants, at a subsequent visit, 6 years later. Since the study has now accrued followup data for fatal CHD events for 430 years, our aim is to assess whether the long-term associations and effect modifications examined in previous studies are also seen in this British cohort, and whether they persist over time. We also consider possible causal pathways to CHD mortality by studying the joint effects of the available Coulter variables, accounting for potential confounders and mediators.
Materials and methods

Recruitment and follow-up
Between 1972 and 1978, NPHS-I recruited 2167 White men and 941 White women of all ages, who had not experienced myocardial infarcts previously, from three occupational groups in northwest London, as reported in greater detail elsewhere. 13 The response to invitations to participate was 80% (there having been some uncertainty about the exact number of employees in one of the groups). Methods for the baseline clinical examination, laboratory measurements and assays, and for follow-up through the NHS Central Register, have also been described earlier. 13 This article deals with fatal CHD events up to 30 June 2006, with notifications of deaths and their causes having been provided by the Office for National Statistics. On receipt of death notifications, enquiries were conducted through general practitioners, hospitals and coroners (where autopsies had been carried out). Summaries of histories from these sources were then submitted for blind, independent assessment of cause of death (as previously described 13 ). Cause of death arising from the assessment process occasionally differed from the certified cause of death and the assessed causes have been used in the analyses. CHD includes myocardial infarction and sudden coronary death, many if not the majority of these cases having been confirmed by autopsy, and a smaller number of cases certified as CHD but with less supporting evidence.
Variables
The Coulter counter automatically gives results for WBC, RBC, Hgb, PCV (also known as haematocrit) and platelet count. Weight, height, body mass index (BMI; kg/m 2 ) and the average of three readings of systolic blood pressure (SBP) were also recorded at the time of recruitment, as well as occupation (manual or not manual), smoking and alcohol consumption history. 13 Additionally, pack-years of cigarettes smoked were calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person had smoked, as reported at study recruitment. In these calculations, 1 g of pipe tobacco was considered to be equivalent to one cigarette, and one cigar to three cigarettes. Cholesterol, triglycerides and a range of haemostatic variables were also measured. 13 All the conventional CHD risk factors for which we had data (namely BMI, SBP, smoking and alcohol consumption, cholesterol, triglycerides and occupation) were treated as potential confounders, as there is not yet a clear understanding of what mechanisms may lead to associations between Coulter variables and CHD.
The Coulter variables and potential confounders were recorded again at the follow-up visit, which on average occurred 6 years after recruitment. We have follow-up data on 65% of the participants because of loss to follow-up (including death) and refusal. However, their main baseline characteristics are similar to those with follow-up data. 14 
Statistical methods
This article deals with fatal CHD events. Follow-up time was calculated from 3 years after entry until a fatal CHD event, death from another cause or 90th birthday. The first 3 years of follow-up were excluded to reduce reverse causality bias, i.e. any effects of incipient CHD on the exposure variables of interest. A censoring date was set as 30 June 2006 to guarantee completeness of information on fatal events.
The effects of entry levels of the haematological variables on time to CHD fatality were estimated by the proportional hazards Cox model, using age as the time-scale and therefore giving rate ratio (RR) estimates that are adjusted for age. 15 Each variable was entered on both a continuous scale, in terms of effect per one standard deviation (SD), and also on a categorical scale, in fourths of the overall distribution. In the latter case, the age-adjusted RRs were computed relative to the lowest fourth. The effects on continuous scales require the assumption of linearity, unlike those on categorical scales, and so both are presented. Likelihood ratio tests were used throughout to assess departures from linear trends and significance of relevant interactions. 15 When the assumption of linearity of effect was rejected, fractional polynomials were used to explore the nature of this departure. 16 Interactions involving continuous variables were based on centred values to avoid numerical instabilities. Interactions with smoking were studied by including an interaction term for categorical smoking status (coded never/ex/current) and one for packyears, with assessment of interaction based on their joint significance.
Age-adjusted RRs associated with each variable of interest were initially computed separately for men and women but, when appropriate, were combined. Adjustment for potential confounders was carried out by including confounders, either singly or jointly, in the relevant Cox regression model for the Coulter variable of interest. Comparisons of the estimated exposure RR with/without adjustment informed us on the possible presence of confounding. All analyses were also performed on the subset of subjects without missing values in the potential confounders. Table 1 summarizes the main characteristics of the 2064 White men and 887 White women who survived 53 years after recruitment and who had information on at least one haematological variable. Ages at entry ranged from 17 to 88 years, with medians of 48 in both genders. The anthropometric, biochemical and haematological variables reflect the expected values and distributions; smoking patterns reflect those among UK workers in the 1970s. 17 The self-reported alcohol consumption shows a surprisingly high prevalence of non-drinkers, probably as a consequence of underreporting.
Results
By the end of June 2006, out of the 2931 participants included in these analyses, 849 men and 247 women had died of all causes, with respectively 222 deaths in men and 36 deaths in women due to CHD. Published analyses on an earlier version of these data 14 showed that, as expected, CHD rates rise with increasing levels of the established risk factors, e.g. SBP and BMI. Table 2 shows results for the associations of the Coulter variables with CHD mortality separately in men and women. Mortality rises with increasing values of RBC (test for trend across categories: P ¼ 0.06), Hgb (P ¼ 0.03) and PCV (P ¼ 0.01) in men. There is, however, no significant association with WBC. Results in women are similar, though none is significant with the possible exception of PCV (test for trend across categories P ¼ 0.07 and significant at 5% level for the continuous scale). Since there was no evidence of effect modification by gender in any of these analyses, further estimates are based on the combined data from men and women. Table 3 extends the study of CHD mortality rates by adjusting the RRs for potential confounding variables, with the unadjusted estimates reported for comparative purpose only. Gender partly explains the crude effects of all the haematological variables, although those for RBC and PCV remain significant for both their categorical (in terms of linear trend) and continuous scales, whereas Hgb shows a significant linear trend only on the categorical scale. After full adjustment for gender, BMI, smoking status and pack-years of smoking, SBP and alcohol consumption (the 'fully adjusted' model), the only borderline significant result is found for PCV on the continuous scale [RR per 1 SD increase ¼ 1.17, 95% confidence interval (CI) 1.00-1.37]. There is also an indication of a threshold effect for this variable when categorized. Further adjustment for occupation did not affect these results. Cholesterol and triglycerides had large numbers of missing values (for more than 150 participants, 12 of whom were cases). Controlling for these variables in analyses of those with complete records showed no evidence of confounding. Thus most of the changes in estimated effects are due to gender, although smoking additionally explains some of the unadjusted associations found for WBC, and BMI and SBP those for RBC, Hgb and PCV. Of note is the lack of evidence of a confounding effect due to alcohol consumption, which may be explained by possible underreporting (data not shown). There is also some evidence of departure from linearity in the effect of (continuous) RBC. This was explored using fractional polynomial regression but did not identify any Table 2 Gender-specific CHD mortality rates per 10 000 person-years and RRs by haematological variables in quartiles for 3074 participants with substantial non-linearity. None of these results suggests departure from proportionality of effects, and therefore of interaction with the time-scale, age. To assess the possible effect modification of smoking identified in previous studies, we also estimated the effects of all Coulter variables in separate strata defined by smoking status. We found higher RRs associated with RBC, Hgb and PCV in non-smokers than in current or ex-smokers, whereas RRs associated with platelet count were higher among ex-smokers. Thus, although tests for interaction do not reach statistical significance, there is some evidence of effect modification of smoking especially for RBC and Hgb (Supplementary Table 1 available as supplementary data at IJE online).
LONG-TERM ASSOCIATION OF COULTER VARIABLES ON CHD
To study whether the effects of each of the haematological variables varied with duration of follow-up time, we re-estimated gender-adjusted and fully adjusted RRs using different time intervals defined by censoring follow-up at the end of 1988, 1993 and 1998, corresponding to 15, 20 and 25 years of follow-up (data not shown). Overall, results were consistent across the different follow-up periods, and with the complete follow-up results reported in Table 3 .
An additional assessment of the stability of the estimated effects was carried out by repeating the analyses using the measurements taken at the follow-up visit that occurred 6 years after recruitment (Supplementary Tables 2 and 3 available as supplementary data at IJE online). We have used the follow-up measurements on their own, the difference between the follow-up and entry values and also their average, with the aim of reducing the impact of any measurement error. In each case, the fully adjusted RRs are controlled for smoking as recorded at follow-up. The estimated effects of the follow-up WBC measures are stronger than those found for entry WBC, unlike those for the other Coulter variables, for which estimates across time were comparable (Supplementary Table 2 available as supplementary data at IJE online). Similarly, the RRs for changes from entry to follow-up are strongest for WBC (Supplementary Table 3 available as supplementary data at IJE online). To assess whether these results were due to selection bias, we re-estimated the association between entry values of WBC and CHD mortality in the subset of those with follow-up data and found slightly raised RRs (effect per 1 SD increase: gender-adjusted RR ¼ 1.10, 95% CI 0.95-1.27; fully adjusted RR ¼ 1.00; 95% CI 0.85-1.17). This increase in RR was not seen for other Coulter variables. Furthermore, since the results based on mean WBC were closer to those based on entry values (Supplementary Table 3 available as supplementary data at IJE online), it is possible that both selection bias and measurement error affect these WBC estimates. The smaller numbers involved, and therefore limited power, should also be considered Table 3 Unadjusted and multiply adjusted (RRs) for CHD mortality by entry values of haematological variables for participants with 53 years of follow-up 
Discussion
The main feature of our results is the assessment of the long-term association with CHD mortality for a wide range of Coulter haematological variables. As indicated, we have omitted outcome events occurring within the first 3 years of follow-up to avoid any possibility of 'reverse causality' by which associations might be due to the effect of early CHD on any of the Coulter variables, especially perhaps WBC. Reassuringly, the results restricted to these study participants actually did not differ substantially from those found using the complete dataset. We found that entry RBC, PCV and Hgb were significant risk factors for CHD mortality after adjustment for gender, but only PCV remained significant after adjustment for potential confounders. We could not adjust for regular medication at entry or during follow-up as this information was not available in this study. It should be noted, however, that NPHS-I started in 1972 when many of the medications now in use were either not available or were only rarely taken.
These findings were consistent with those obtained when censoring follow-up times after 15, 20 and 25 years of follow-up, and with those based on the 6-year follow-up measurements. The latter results additionally showed moderate associations for WBC, which are, however, consistent with a greater amount of measurement error affecting this variable (e.g. due to unrecognized drift), as well as possibly biased selection of participants with follow-up data (although there were no obvious differences in baseline characteristics between the full cohort and those re-examined 6 years later).
In view of the central role of platelets in thrombosis and CHD, and of the increase in thrombotic events in thrombocytosis, it is perhaps surprising that we found no association of platelet count with CHD mortality, in line with an earlier report from NPHS-I. 9 On the other hand, one study has described greater risk of Model adjusted by gender, smoking, BMI, SBP and alcohol consumption.
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CHD with increased counts. 8 There is possibly more consistency in secondary prevention, where platelet hyperreactivity influenced prognosis in survivors of myocardial infarction 18 and platelet size was associated with outcome after myocardial infarction. 19 Overall, the most consistent association is for increasing risk with increasing PCV which in some analyses was paralleled by an association of RBC. This is not surprising in view of the strong correlation between these two variables (r ¼ 0.82). In the long term, on which our results are based, it is perhaps surprising that the association between WBC and risk is not stronger or more consistent, in contrast with the findings of several other studies that were generally based, however, on shorter follow-up periods. 1, 4, 7 Our results suggest no place for Coulter variables in helping predict those at high risk of CHD death, partly because the fully adjusted effects were very weak, but also because there is little to be added in predictive terms once the main risk factors such as hypertension, smoking and obesity have been taken into account. 20, 21 However, our results do throw possible lights on pathways through which red cells/PCV may help to promote thrombosis. In a laboratory study, Bradlow suggested that red cells liberate material with thromboplastic activity and this material mainly originates from the surface of red cells. 22 This idea was later reinforced by Peyrou et al. 23 and Horne et al., 12 who proposed that red cell microparticles may augment thrombin generation, an effect also demonstrated for the haematocrit. These laboratory observations are consistent with our findings on RBC and PCV, which may therefore have causal implications for CHD mortality. Further work on the relationship between RBC and PCV with indices of thrombin metabolism would be valuable in confirming or refuting this suggestion.
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